Know Cancer

or
forgot password
  • cancer clinical trials in chapel hill, NC

  • Oxaliplatin, Gemcitabine, Erlotinib, and Radiation Therapy in Treating Patients With Unresectable and/or Metastatic Pancreatic Cancer or Biliary Tract Cancer
    Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
    Chapel Hill, North Carolina 27599-7570
    Extrahepatic Bile Duct Cancer, Gallbladder Cancer, Pancreatic Cancer
    A Survival Study for Women With Advanced Lung Cancer Who Have Not Previously Received Chemotherapy.
    UNC Chapel Hill Oncology Protocol Office
    Chapel Hill, North Carolina 27599
    NSCLC
    Aspirin/Folate Prevention of Large Bowel Polyps
    University of North Carolina
    Chapel Hill, North Carolina 27599
    Colorectal Cancer, Polyps, Adenomas
    Combination Chemotherapy, Bev, RT, and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer
    Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
    Chapel Hill, North Carolina 27599-7570
    Lung Cancer
    Bortezomib, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Rectal Cancer
    Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
    Chapel Hill, North Carolina 27599-7570
    Colorectal Cancer
    Carboplatin and Docetaxel After Surgery in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
    University of North Carolina Lineberger Comprehensive Cancer Center
    Chapel Hill, North Carolina 27599
    Lung Cancer
    Whole-Brain Radiation Therapy and Pemetrexed in Treating Patients With Brain Metastases From Non-Small Cell Lung Cancer
    Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
    Chapel Hill, North Carolina 27599-7570
    Lung Cancer, Metastatic Cancer
    Induction Chemotherapy Using Paclitaxel, Carboplatin, CPT-11 With Pegfilgrastim
    University of North Carolina Lineberger Comprehensive Cancer Center
    Chapel Hill, North Carolina 27599
    Non Small Cell Lung Cancer
    Study of Amantadine for Weight Stabilization During Olanzapine Treatment
    University of North Carolina at Chapel Hill
    Chapel Hill, North Carolina 27599
    Psychotic Disorder, Schizophreniform Disorder, Schizophrenia, Schizoaffective Disorder, Mood Disorders With Psychotic Features
    Safety and Efficacy of SDX-101 (R-Etodolac) in Patients With Relapsed or Refractory Multiple Myeloma (MM)
    University of North Carolina at Chapel Hill
    Chapel Hill, North Carolina 27599
    Multiple Myeloma
    Donor Stem Cell Transplant in Treating Young Patients With Myelodysplastic Syndrome, Leukemia, Bone Marrow Failure Syndrome, or Severe Immunodeficiency Disease
    Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
    Chapel Hill, North Carolina 27599-7570
    Congenital Amegakaryocytic Thrombocytopenia, Leukemia, Myelodysplastic Syndromes, Severe Congenital Neutropenia
    Priapism in Boys and Men With Sickle Cell Disease - Demographics, Characteristics and Prevalence
    University of North Carolina at Chapel Hill
    Chapel Hill, North Carolina 27599
    Priapism, Anemia, Sickle Cell
    Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Gemcitabine in Treating Patients With Advanced Metastatic Solid Tumors
    University of North Carolina Lineberger Comprehensive Cancer Center
    Chapel Hill, North Carolina 27599
    Unspecified Adult Solid Tumor, Protocol Specific
    Irinotecan and Temozolomide in Treating Young Patients With Recurrent Neuroblastoma
    Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
    Chapel Hill, North Carolina 27599-7570
    Neuroblastoma
    Liposomal SN-38 in Treating Patients With Metastatic Colorectal Cancer
    Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
    Chapel Hill, North Carolina 27599-7570
    Colorectal Cancer
    Using Magnetic Resonance Spectroscopy With MRI to Non-invasively Determine Breast Cancer Extent of Disease
    Mammography Clinic - UNC Hospitals
    Chapel Hill, North Carolina 27514
    Breast Cancer
    Vinflunine and Erlotinib or Pemetrexed in Treating Patients With Unresectable or Metastatic Solid Tumors
    Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
    Chapel Hill, North Carolina 27599-7570
    Unspecified Adult Solid Tumor, Protocol Specific
    A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
    University of North Carolina
    Chapel Hill, North Carolina 27599
    Oral Mucositis, Stomatitis
    GM-CSF With or Without Vaccine Therapy After Combination Chemotherapy and Rituximab as First-Line Therapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma
    Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
    Chapel Hill, North Carolina 27599-7570
    Lymphoma
    Bortezomib, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory Low-Grade, Follicular, or Mantle Cell Non-Hodgkin's Lymphoma
    Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
    Chapel Hill, North Carolina 27599-7570
    Lymphoma
    Phase 2 Study of VX-950, Pegasys®, and Copegus® in Hepatitis C
    Call For Information
    Chapel Hill, North Carolina
    Chronic Hepatitis C
    Fibroid Growth Study
    University of North Carolina Medical Center
    Chapel Hill, North Carolina
    Uterine Leiomyomas
    Prevention of Tumor Spread Due to Lung Cancer Surgery
    University of North Carolina at Chapel Hill
    Chapel Hill, North Carolina 27599
    Lung Cancer, Non-Small Cell Lung Cancer
    The Second Multicenter Hemophilia Cohort Study
    University of North Carolina
    Chapel Hill, North Carolina 27599
    Liver Decompensation, Hepatocellular Carcinoma, Non-Hodgkin Lymphoma
    A Study of SB-743921 in Non-Hodgkin's Lymphoma
    University of North Carolina
    Chapel Hill, North Carolina 27599
    Non-Hodgkin's Lymphoma, Hodgkin's Disease
    Quit Smoking Program for Lung Cancer Patients' Families (The Family Ties Project)
    UNC Chapel Hill Multidisciplinary Thoracic Oncology Program
    Chapel Hill, North Carolina 27599
    Smoking Cessation
    High-Dose Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Metastatic Rhabdomyosarcoma or Ectomesenchymoma
    Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
    Chapel Hill, North Carolina 27599-7570
    Sarcoma
    Study of Dasatinib (BMS-354825) in Patients With Advanced Estrogen/Progesterone Receptor-positive (ER+/PR+) or Her2/Neu-positive (Her2/Neu+)Breast Cancer
    University of North Carolina at Chapel Hill
    Chapel Hill, North Carolina 27599
    Breast Cancer, Metastasis
    Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
    Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
    Chapel Hill, North Carolina 27599-7570
    Leukemia
    Trabectedin in Treating Patients With Advanced, Persistent, or Recurrent Leiomyosarcoma of the Uterus
    Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
    Chapel Hill, North Carolina 27599-7570
    Sarcoma
    Lapatinib and Radiation Therapy in Treating Patients With Locally Recurrent or Chemotherapy-Refractory Locally Advanced or Metastatic Breast Cancer
    Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
    Chapel Hill, North Carolina 27599-7570
    Breast Cancer
    Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia
    University of North Carolina
    Chapel Hill, North Carolina 27599
    B-cell Childhood Acute Lymphoblastic Leukemia, L1 Childhood Acute Lymphoblastic Leukemia, L2 Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Lymphoblastic Leukemia
    Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission
    University of North Carolina
    Chapel Hill, North Carolina 27599
    B-cell Childhood Acute Lymphoblastic Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Graft Versus Host Disease, L1 Childhood Acute Lymphoblastic Leukemia, L2 Childhood Acute Lymphoblastic Leukemia, T-cell Childhood Acute Lymphoblastic Leukemia
    A Study of Abatacept in Patients With Active Crohn's Disease
    University of North Carolina at Chapel Hill
    Chapel Hill, North Carolina 27599
    Crohn's Disease
    Cisplatin and Radiation Therapy With or Without Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Head and Neck Cancer
    University of North Carolina
    Chapel Hill, North Carolina 27599
    Stage III Squamous Cell Carcinoma of the Hypopharynx, Stage III Squamous Cell Carcinoma of the Larynx, Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage III Squamous Cell Carcinoma of the Nasopharynx, Stage III Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx
    Prophylactic Use of Maribavir for the Prevention of Cytomegalovirus (CMV) Disease in Stem Cell Transplant Recipients
    University of North Carolina Hospital
    Chapel Hill, North Carolina 27599
    Cytomegalovirus Infections
    BI 2536 Second Line Monotherapy in SCLC
    1216.11.001 Boehringer Ingelheim Investigational Site
    Chapel Hill, North Carolina
    Carcinoma, Small Cell
    Phase II Trial of BIBW 2992 in Patients With HER2-positive Metastatic Breast Cancer After Failure of Trastuzumab Therapy
    1200.11.5 Boehringer Ingelheim Investigational Site
    Chapel Hill, North Carolina
    Breast Neoplasms
    Visibility of Lesion Characteristics With Phase Contrast Mammography
    Carolina Center for Clinical Trials, University of North Carolina
    Chapel Hill, North Carolina 27599
    Breast Cancer
    Cytarabine in Treating Young Patients With Recurrent or Refractory Ewing's Sarcoma
    Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
    Chapel Hill, North Carolina 27599-7570
    Sarcoma
    A Phase 1 Study Investigating the Combination of RAD001, Cetuximab and Irinotecan as Second-line Therapy After FOLFOX (or XELOX) Plus Bevacizumab in Patients With Metastatic Colorectal Cancer
    UNC School of Medicine
    Chapel Hill, North Carolina 27599
    Colorectal Cancer, Colorectal Carcinoma, Colorectal Tumors, Neoplasms, Colorectal
    A Phase 1 / 2 Dose Escalation Study of Locally-Administered OncoGel™ in Subjects With Recurrent Glioma
    University of North Carolina at Chapel Hill
    Chapel Hill, North Carolina 27599
    Glioblastoma Multiforme, Brain Neoplasms
    cRisk-Group Classification of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
    Chapel Hill, North Carolina 27599-7570
    Leukemia
    Oxaliplatin, Capecitabine, and Cetuximab in Treating Patients With Advanced Liver Cancer
    Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
    Chapel Hill, North Carolina 27599-7570
    Liver Cancer
    Low Antioxidant Diet in Controlling Cachexia in Patients With Oropharyngeal Cancer Receiving Chemotherapy and Radiation Therapy
    Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
    Chapel Hill, North Carolina 27599-7570
    Cachexia, Head and Neck Cancer, Weight Changes
    Efalizumab in Treating Patients With Graft-Versus-Host Disease of the Skin That Did Not Respond to Previous Steroids
    Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
    Chapel Hill, North Carolina 27599-7570
    Graft Versus Host Disease
    Doppler-Guided Uterine Artery Occlusion (DUAO) Device for Fibroid Related Bleeding
    North Carolina Children's & Adults' Clinical Research Foundation
    Chapel Hill, North Carolina 27514
    Menorrhagia, Uterine Fibroids
    Cetuximab in Treating Patients With Persistent or Recurrent Cervical Cancer
    Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
    Chapel Hill, North Carolina 27599-7570
    Cervical Cancer
    Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
    Chapel Hill, North Carolina 27599-7570
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Fludeoxyglucose F 18-PET Imaging for Early Detection of Residual Disease in Patients Undergoing Radiofrequency Ablation of Liver Metastases From Colorectal Cancer
    Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
    Chapel Hill, North Carolina 27599-7570
    Colorectal Cancer, Metastatic Cancer
    Individualized Exercise Programs for Patients Receiving Chemotherapy for Newly Diagnosed Acute or Relapsed Myeloid Leukemia or Lymphoblastic Leukemia
    Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
    Chapel Hill, North Carolina 27599-7570
    Depression, Fatigue, Leukemia, Musculoskeletal Complications, Psychosocial Effects of Cancer and Its Treatment
    PTK787 in Refractory or Relapsed Diffuse Large Cell Lymphoma
    University of North Carolina at Chapel Hill
    Chapel Hill, North Carolina 27599
    Lymphoma, Large-Cell, Diffuse
    Fluorouracil, Oxaliplatin, and Leucovorin in Treating Patients With Metastatic Stomach Cancer or Gastroesophageal Junction Cancer
    Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
    Chapel Hill, North Carolina 27599-7570
    Gastric Cancer
    BIBW 2992 (Afatinib) in Head & Neck Cancer
    1200.28.0017 Boehringer Ingelheim Investigational Site
    Chapel Hill, North Carolina
    Head and Neck Neoplasms, Carcinoma, Squamous Cell
    Vincristine, Topotecan, and Cyclophosphamide With or Without Bevacizumab in Treating Young Patients With Refractory or First Recurrent Extracranial Ewing Sarcoma
    Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
    Chapel Hill, North Carolina 27599-7570
    Sarcoma
    Vinflunine and Cetuximab as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
    Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
    Chapel Hill, North Carolina 27599-7570
    Lung Cancer
    Elesclomol (STA-4783) With Paclitaxel Versus Paclitaxel Alone in Melanoma
    UNC School of Medicine - Division of Hematology/Oncology
    Chapel Hill, North Carolina 27599
    Melanoma
    Tezosentan in the Treatment of Acute Heart Failure
    University of North Carolina
    Chapel Hill, North Carolina 27599
    Acute Heart Failure, Acute Decompensation of Chronic Heart Failure, New Onset of Heart Failure
    Exploratory Study, Evaluating the Treatment Effect of Surgery Plus GLIADEL® Wafer in Patients With Metastatic Brain Cancer
    University of North Carolina
    Chapel Hill, North Carolina 27599
    Metastatic Brain Cancer
    Study of CryoSpray Ablation of Low Grade or High Grade Dysplasia Within Barrett's Esophagus
    Universtiy of North Carloina at Chapel Hill
    Chapel Hill, North Carolina 27599
    Barrett's Esophagus, High Grade Dysplasia, Low Grade Dysplasia
    Examining Cognitive Function and Brain Abnormalities in Adults With Sickle Cell Disease
    University of North Carolina at Chapel Hill
    Chapel Hill, North Carolina 27599
    Anemia, Sickle Cell
    Exploratory Study Evaluating Fluorodeoxyglucose - Position Emission Tomography as a Predictive Marker for Therapy With RAD001 in Metastatic Renal Cell Cancer
    The University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center
    Chapel Hill, North Carolina 27599
    Carcinoma, Renal Cell
    A Study of the Monoclonal Antibody CT-011 in Diffuse Large B-Cell Lymphoma Following Autologous Stem Cell Transplantation
    University of North Carolina
    Chapel Hill, North Carolina 27599
    Lymphoma, Large Cell, Diffuse, Lymphoma, Mixed Cell, Diffuse, Primary Mediastinal Large B-Cell Lymphoma, Transformed Follicular Lymphoma, Relapsed
    Erwinia Asparaginase After Allergy to PEG-Asparaginase in Treating Young Patients With Acute Lymphoblastic Leukemia
    Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
    Chapel Hill, North Carolina 27599-7570
    Leukemia
    AMR PH GL 2007 CL001 Phase 3 Trial in Patients With Small Cell Lung Cancer After Failure of First-Line Chemotherapy
    Lineberger Comprehensive Cancer Center
    Chapel Hill, North Carolina 27599-7305
    Small Cell Lung Cancer
    Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study Two
    University of North Caroline-Chapel Hill, Department of Neurology
    Chapel Hill, North Carolina
    Multiple Sclerosis, Relapsing-Remitting
    AZD6244 in Treating Patients With Locally Advanced or Metastatic Liver Cancer
    Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
    Chapel Hill, North Carolina 27599-7570
    Liver Cancer
    Efficacy and Safety of Prochymal™ Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute GVHD
    University of North Carolina Hospitals
    Chapel Hill, North Carolina 27599
    Graft Versus Host Disease
    Sorafenib Combined With Cisplatin and Etoposide or Carboplatin and Pemetrexed in Treating Patients With Metastatic Solid Tumors
    Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
    Chapel Hill, North Carolina 27599-7570
    Unspecified Adult Solid Tumor, Protocol Specific
    A Phase I/Expansion Study of Dasatinib
    UNC Lineberger, Comprehensive Cancer Center
    Chapel Hill, North Carolina 27599
    Refractory Solid Tumors, Pancreatic Adenocarcinoma
    Selumetinib in Treating Patients With Locally Advanced or Metastatic Liver Cancer
    University of North Carolina
    Chapel Hill, North Carolina 27599
    Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer, Recurrent Adult Primary Liver Cancer
    Pre-surgical Detection of Clear Cell Renal Cell Carcinoma Using Radiolabeled G250-Antibody
    UNC School of Medicine-Chapel Hill
    Chapel Hill, North Carolina 27599
    Renal Cell Carcinoma, Kidney Cancer
    Repair of Infected or Contaminated Hernias
    University of North Carolina Hospitals
    Chapel Hill, North Carolina 27599
    Hernia
    Larotaxel + Cisplatin Versus Gemcitabine + Cisplatin in First Line Treatment of Locally Advanced/Metastatic Urothelial Tract or Bladder Cancer
    Sanofi-Aventis Investigational Site Number 840041
    Chapel Hill, North Carolina 27599
    Urinary Bladder Neoplasms